Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia
Survival by light chain type for IgG and IgA myeloma stratified by the... | Download Scientific Diagram
Frontiers | Pro- and Anti- Effects of Immunoglobulin A- Producing B Cell in Tumors and Its Triggers
The "four hit" hypothesis of IgA nephropathy. Hit 1: Appearance in... | Download Scientific Diagram
Structure and function relationships in IgA | Mucosal Immunology
PE Goat F(ab')2 Anti-Human IgA | SouthernBiotech
Recurrent atypical antiglomerular basement membrane nephritis in the kidney transplant - American Journal of Transplantation
Multiple Myeloma and the 4;14 Translocation - HealthTree for Multiple Myeloma
Multiple Myeloma | SpringerLink
t(4;14)(p16;q32) IGH/FGFR3 and WHSC1
Outcome of stage III-B IgA-Kappa FLC MM with t(4:14) karyotype: A Nigerian jehovah witness nine-year experience
Multiple myeloma with t(11;14): impact of novel agents on outcome | Blood Cancer Journal
Human IgA kappa chain, Polyclonal Isotype Control Antibody (ab206207) | Abcam
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
Frontiers | Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months
Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...
IGA-2, Tina-quant IgA Gen.2
Multiple myeloma with t(11;14): impact of novel agents on outcome | Blood Cancer Journal
Mouse IgA Isotype Control (14-4762-81)
